Metabolic
Survodutide
Weight
16
Amino acids
Molecular weight
Peptide
Type
Investigational dual receptor agonist targeting metabolic disease through balanced GLP-1R and GCGR activation. Phase 2/3 clinical trials demonstrate superior weight loss and MASH treatment efficacy.
Top researched benefits
Overview of Survodutide
Dual agonism: GLP-1R reduces appetite and slows gastric emptying; GCGR increases energy expenditure and hepatic fat oxidation. EC50 0.52nM GCGR, 0.33nM GLP-1R.
Weight Loss
- 14.9% mean weight loss at 46 weeks (4.8mg); 55% achieved ≥15% reduction.
- Superior to semaglutide: -8.7% vs -5.3% at 16 weeks.
- Dual mechanism addresses both energy intake and expenditure.
Metabolic
- 62% achieved MASH improvement without fibrosis worsening at 4.8mg.
- 63-67% achieved ≥30% liver fat reduction.
- HbA1c reduction up to -1.6% at highest doses.
Storage
Reconstituted: 2-8°C immediately after mixing
Frequency
Once weekly (same day each week)
Typical Dose
0.6mg starting, titrate up to 3.6-6.0mg weekly
Cycle Duration
24-76+ weeks continuous therapy
Chemical Makeup
Key benefits
Superior weight loss vs monotherapy (14.9% at 46 weeks)
Once-weekly convenient dosing
Proven efficacy in obesity, MASH, and Type 2 diabetes
62% MASH improvement in clinical trials
Community interest
This peptide is still gaining traction in the community.
Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesSurvodutide Molecular Information
View the scientifc details of Survodutide.
16
Amino Acids
Survodutide
Ala
Ala
Position 1
Met
Met
Position 2
Ile
Ile
Position 3
Asn
Asn
Position 4
Pyl
Pyl
Position 5
Ala
Ala
Position 6
Cys
Cys
Position 7
Ile
Ile
Position 8
Asp
Asp
Position 9
Pro
Pro
Position 10
Glu
Glu
Position 11
Pro
Pro
Position 12
Thr
Thr
Position 13
Ile
Ile
Position 14
Asp
Asp
Position 15
Glu
Glu
Position 16
Molecular Weight
0DaChain Length
16Amino AcidsType
PeptideSurvodutide Protocols
Subcutaneous injection to abdomen (2+ inches from navel), upper thigh, or upper arm. Any time of day, with or without food.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Obesity - Conservative Start | 0.6 | 4 week range | SubQ |
| Obesity - Standard Protocol | 3.6 | 1 week range | SubQ |
| MASH Treatment | 2.4 | 1 week range | SubQ |
| Type 2 Diabetes | 0.3 | 1 week range | SubQ |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Remove vial from refrigerator; allow 15-30 minutes to reach room temperature
- Clean rubber stoppers with alcohol swabs
- Draw prescribed amount of bacteriostatic water
- Insert needle at 45-degree angle into vial
- Inject BAC water down vial side slowly to minimize foaming
- Gently swirl (do not shake vigorously)
- Allow 2-3 minutes for complete dissolution
- Solution should be clear to slightly opalescent without particles
- Store reconstituted solution in refrigerator immediately
Survodutide Cycle
The Survodutide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 1-4
- Possible nausea, reduced appetite (most common during escalation)
- Week 4-8
- Initial weight loss begins; improved satiety between meals
- Week 8-16
- Progressive weight loss; potential energy level improvements
- Week 16-24
- Approaching steady-state; more consistent effects
- Week 0-0
- Sustained weight loss; average 15-19% by week 46
Dosing tools
Survodutide Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Survodutide
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Survodutide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Survodutide
- Dosing
- 0.6mg starting, titrate up to 3.6-6.0mg weekly
- Dosing Frequency
- Once weekly (same day each week)
- Cycle Duration
- 24-76+ weeks continuous therapy
- Storage
- Reconstituted: 2-8°C immediately after mixing
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Side effects
Contraindications
Not recommended in pregnancy or breastfeeding
Use contraception during treatment
Stop signs
Severe persistent nausea/vomiting preventing oral intake
Signs of pancreatitis (severe abdominal pain radiating to back)
Allergic reactions (rash, itching, difficulty breathing)
Severe hypoglycemia with insulin/sulfonylureas
Gallbladder symptoms (right upper quadrant pain)
Significant tachycardia or arrhythmias
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
SurvodutideResearch References
Survodutide is an extensively studied compound
Survodutide
Survodutide is an extensively studied compound
Phase 2 Obesity Trial Without Diabetes
387 participants; BMI ≥27 kg/m²; 46 weeks. 14.9% mean weight loss at 4.8mg; 83% achieved ≥5%, 69% achieved ≥10%, 55% achieved ≥15%.
2024
Phase 2 MASH and Fibrosis Trial
293 participants with biopsy-confirmed MASH; 48 weeks. MASH improvement: 62% (4.8mg) vs 14% placebo; 63-67% achieved ≥30% liver fat reduction.
2024
Phase 2 Type 2 Diabetes Trial
Head-to-head vs semaglutide 1.0mg; 16 weeks. Survodutide -8.7% weight loss vs semaglutide -5.3%; HbA1c reduction up to -1.6%.
2023